Travelers Vaccines Market Share, Growth, Region Wise Analysis of Top Players, Application and Forecasts by 2022


Global Travelers Vaccines Market is segmented on the basis of product types, application and geography. The agent stimulates the immune system of the body for identifying the agent as foreign, destroying it, and “remembering” it, so that the immune system could easily recognize and destroy any of these microorganisms that it later encounters is termed as a vaccine.

                     


The introduction of additional age group coverage is one of the primary factors driving the travelers vaccines market’s growth. While approving a vaccine, the regulatory authorities also specify the age group approved for receiving the vaccine. This age group is particular on the vaccine label and is based on the efficacy and safety results obtained from clinical trials conducted using individuals from these age groups. Label expansion to include additional age groups approved for immunization requires additional regulatory approval.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/travellers-vaccines-market

These approvals are based on the additional clinical trials conducted using individuals from additional age groups. The increase in approvals for additional age group coverage will increase the patient population for the vaccine, thereby propelling the travelers vaccines market’s growth in the coming years. Based on product types, the Travelers Vaccines Market is classified as japanese encephalitis vaccine, meningococcal vaccine, rabies vaccine, yellow fever vaccine, typhoid vaccine, hepatitis B vaccine, hapatitis A vaccine, cholera vaccine, combination vaccine and mono vaccine.

The segment “combination vaccines” is one of the fastest rising segments of the travelers vaccines market. These vaccines present protection against different causative agents for diseases such as meningitis, measles, rubella, mumps, diphtheria, pertussis and tetanus.  Menhibrix and Menitronix are the most commonly used combination vaccines. While Menhibrix is approved for the prevention of invasive disease caused by Haemophilus influenzae type b and N, meningitidis serogroups C and Y. Menitronix is approved for the prevention of invasive diseases caused by N. meningitidis serogroup C and H. influenzae type b. Moreover, combination vaccines ensure better patient compliance, which will also contribute to this segment’s growth in the coming years.

Based on application, the Travelers Vaccines Market is classified as tourists, students, workers and so on. Based on geography, the travelers vaccines market is classified as Middle East & Africa, Latin America, Europe, Asia Pacific and North America. The North America was the highest profits contributing region in the market during 2015 and will continue to lead the market in the coming years. The U.S. was one of the highest revenue contributors in the region, capturing a significant portion of the market.  The increasing demand for vaccines that provide to the unmet medical needs provides an opportunity for vendors to develop new safe and efficient molecules, which will assist in the growth of the travelers vaccines market in the region.

The key players of travelers vaccines market are Sanofi Pasteur, Glaxosmithkline/ Novartis, Pfizer, Merck, Biokangtai, Sanofi Pasteur Msd, Cnbg, Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Merck, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva and Zydus Cadila.

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/travellers-vaccines-market/request-sample



Comments

Post a Comment

Popular posts from this blog

Advancing Hydrogen Production Through Next Generation Electrolyzer Technologies

  Electrolyzers are at the center of the global transition toward clean energy and decarbonization. By using electricity to split water into hydrogen and oxygen, electrolyzers enable the production of green hydrogen when powered by renewable sources such as solar and wind. As governments and industries seek alternatives to fossil fuels, electrolyzer technology is rapidly evolving to deliver higher efficiency, scalability, and cost effectiveness. Hydrogen produced through electrolysis offers significant potential for decarbonizing hard to abate sectors including heavy industry, transportation, and power generation. Unlike conventional hydrogen production methods that rely on natural gas reforming, electrolyzers provide a pathway to low carbon hydrogen, supporting climate goals and long term energy security. Technology Advancement Across Electrolyzer Several electrolyzer technologies are currently shaping the industry, each offering distinct advantages. Alkaline electrol...
Read more

Drug Discovery Outsourcing Driving Faster Innovation and Smarter R&D Strategies

  Drug discovery outsourcing has emerged as a strategic approach for pharmaceutical and biotechnology companies seeking to enhance efficiency, reduce costs, and accelerate innovation. As therapeutic research becomes increasingly complex, organizations are turning to specialized external partners to manage critical aspects of the discovery pipeline. By leveraging advanced technologies, global expertise, and scalable infrastructure, outsourcing has become a cornerstone of modern drug development strategies. The early stages of drug development require significant investment in target identification, lead optimization, preclinical testing, and regulatory documentation. Managing these processes internally can strain resources and extend development timelines. Drug discovery outsourcing allows companies to access experienced scientific teams, state of the art laboratories, and advanced analytical tools without bearing the full burden of capital expenditure. Benefits of Out...
Read more

How Urbanization and Mega Infrastructure Projects Are Driving Ferrosilicon Demand

  Ferrosilicon is a vital alloy composed primarily of iron and silicon, widely used in steelmaking and foundry applications. It plays a critical role as a deoxidizer and alloying element, enhancing the strength, durability, and corrosion resistance of steel and cast iron. Produced in electric arc furnaces through the reduction of silica with coke in the presence of iron, ferrosilicon remains indispensable to modern industrial development. As global construction, manufacturing, and clean energy initiatives accelerate, the demand for ferrosilicon continues to evolve in response to changing industrial priorities. Infrastructure and Urbanization Driving Demand Rapid urbanization and infrastructure expansion across emerging and developed economies are key drivers of ferrosilicon consumption. Governments worldwide are investing heavily in transportation networks, smart cities, bridges, residential complexes, and industrial corridors. These projects require substantial volume...
Read more